Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

NCT02248844 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02248844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02248844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
September 26, 2014
Completion date
August 14, 2017
Enrollment
667 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crow's feet lines, lateral canthal lines